Please login to the form below

Not currently logged in
Email:
Password:

Dr Arndt Schottelius to lead Kymab’s R&D

He takes up the newly-created role of executive vice president of R&D

Kymab Dr Arndt SchotteliusCambridge, UK-based Kymab has appointed Dr Arndt Schottelius to the newly-created position of executive vice president of research and development.

Dr Schottelius will take on responsibility for the human monoclonal antibody specialist's R&D activities, including pre-clinical and clinical developments, from May this year.

He joins from MorphoSys, where he has been chief development officer since 2008, overseeing a portfolio of therapeutic antibody programmes in oncology and immunology.

Previously, Dr Schottelius was medical director of immunology development at Genentech based in San Francisco, US, and held scientific and management positions in immunology research at Berlex Biosciences in California, US and Schering AG in Berlin, Germany.

Dr David Chiswell, chief executive of Kymab, said: “I am delighted to welcome Dr Schottelius to the Kymab team.

“His strong management expertise developed at both MorphoSys AG and Genentech as well as his unique experience and track record in drug development supports our commitment to pursue the opportunities in our R&D programmes following our recent $100m Series C funding.

“Dr Schottelius' appointment validates the current strength and exciting potential of our growing product pipeline.”

3rd February 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

CBC
Building Europe’s next breakthrough biotechs
Start Codon's Daniel Rooke on fostering biotech success in Cambridge, UK...
Tactful screening & participant sensitivity
Screening participants can involve asking personal questions that could be perceived as intrusive. Here CMR explores the implications of such lines of questioning....
Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...

Infographics